Thermo Fisher, Symphogen to simplify study of Complex Therapeutic Proteins

Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused...

October 30, 2018 | Tuesday | News
Bio-Rad IH-reader 24 receives FDA clearance

Singapore – The FDA grants 510(k) clearance for Bio-Rad Laboratories' IH-Reader 24, a semi-automated blo...

October 30, 2018 | Tuesday | News
Takeda offers to divest Shire drug to satisfy EU regulators

Singapore – Aimed at satisfying European Commission (EC) concerns about the potential overlap in the inflammatory ...

October 30, 2018 | Tuesday | News
EBD opens its partneringONE Platform for BIO-Europe 2018

EBD Group (EBD), the market-leading provider of world-class partnering events and tools for the global life science...

October 29, 2018 | Monday | News
Elpis human cells can replace animal experiments in Drug Discovery

Elpis Biomed Ltd. (Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OP...

October 26, 2018 | Friday | News
M3 biotechnology appoints leaders in Alzheimer's research, CNS drug development and clinical trial design

M3 Biotechnology, a Seattle-based therapeutics company dedicated to developing, first-in-class, therapies for Alzhe...

October 26, 2018 | Friday | News
ICON Wins Pharma Contract Services Company of the Year Award

ICON plc, (NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology and me...

October 25, 2018 | Thursday | News
Pfizer, Bain Capital create new company Cerevel Therapeutics

Bain Capital and  Pfizer have announced the creation of Cerevel Therapeutics,  a new biopharmaceutical company...

October 24, 2018 | Wednesday | News
AstraZeneca expands collaboration with Innate Pharma

AstraZeneca, and its global biologics research and development arm MedImmune, have announced a new multi-term agreement ...

October 24, 2018 | Wednesday | News
Pfizer, Eli Lilly’s non-opioid drug helps reduce osteoarthritis pain

Singapore – A non-opioid drug developed by Pfizer and Eli Lilly met the main go...

October 24, 2018 | Wednesday | News
Synthego Receives $110M in Funding to Accelerate Global Access to Genome Engineering

Synthego, a leading genome engineering innovation company, today announced a $110 million Series C financing round led b...

October 24, 2018 | Wednesday | News
Kibow Biotech to exhibit Its "Enteric Dialysis" Technology at ASN 2018

Kibow Biotech is proud to announce its 21st year of operations as a pioneer with the use of Pro/Prebiotics in people wit...

October 24, 2018 | Wednesday | News
Epilepsy Society, UCL, Congenica unite to identify cause of epileptic death

Congenica, the global diagnostic decision support platform provider, announced a key partnership with the UK’s&nbs...

October 23, 2018 | Tuesday | News
Stream Bio expands its CPN products distribution network across Europe

Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, is expand...

October 23, 2018 | Tuesday | News
AstraZeneca's Lynparza shown to cut cancer progression by 70%

AstraZeneca and Merck  have announced detailed results from the Phase III SOLO-1 trial testing Lynparza (...

October 22, 2018 | Monday | News
FDA approves Regeneron, Sanofi's Dupixent for asthma treatment

Singapore - The FDA approves Regeneron Pharmaceuticals and development partner Sanofi's DUPIXENT (dupilumab) a...

October 22, 2018 | Monday | News
Roche's Tecentriq extends progression-free survival in TNBC

Singapore - Results from a Phase 3 clinical trial, IMpassion130, evaluating Roche unit Genentech's TECENTRIQ (...

October 22, 2018 | Monday | News
Luminex to acquire MilliporeSigma’s flow cytometry portfolio

Luminex has signed a definitive agreement to buy MilliporeSigma’s flow cytometry portfolio for $75 million. This ...

October 21, 2018 | Sunday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls